🧬 Vitalik Buterin is Bullish on Rapamycin

Welcome, humans. This is Ambrosia Path, the free weekly newsletter that helps you stay up to date on the latest longevity news in 5 minutes 🤝

Longevity Headlines

• Ethereum founder, Vitalik Buterin, stated that drugs like Rapamycin are making a big impact on the longevity field 💊

• Bryan Johnson slows speed of aging to 0.64x. He now only ages 7.6 months every 12 months 🤯

• Mitrix Bio spearheads trial to extend human lifespan to 130 years with mitochondrial transplantation 👀

• Resistance training partially reverses some of the hallmarks of aging type II muscle fibers 💪

• The world’s oldest man revealed that the secret to longevity is luck 🤞

• SENS Research Foundation and LifespanIO announce intent to merge, forming a novel longevity entity 🤝

• Study shows cooling body temperature can slow aging, extend health in mice 🥶

• New study finds natural plant compounds may replace drugs in reducing age-related diseases by targeting aging cells 🌱

• Northeastern University scientists propose AI framework for mass-manufacturing of ​stem cells for regenerative medicine 🤖

• EnteroBiotix raises $34m to take microbiome therapeutics into clinical trials 💰

• LyGenesis begins trial for liver regeneration using patients' lymph nodes, targeting end-stage liver disease ✅

• Rejuve.AI has revealed that GlycanAge, Vita Authentica, and Peptide Bioregulator are to accept its RJV crypto token as an alternative form of payment on their platforms 💵

• Repair Bio to trial mRNA therapy that tackles cholesterol, aiming to reverse heart disease with favorable preclinical results ❤️

• Study finds dog lifespan linked to breed, size, & head shape, with crossbreeds living longer 🐶

• New drug XSP888 targets elusive senescent cells, promising hope against fibrosis (lung disease) 🫁

That’s it for longevity news today folks! Have a fantastic day!

Hot Tip: If this email landed in your promotions folder, move it to primary to make sure you see the next edition!

Disclaimer: This information does not constitute health and/or financial advice or a recommendation and should not be considered as such